Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Alpha Cognition Inc (ACOG.VN)

Alpha Cognition Inc (ACOG.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 50,705
  • Shares Outstanding, K 67,607
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,545 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.36
Trade ACOG.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.37
  • Most Recent Earnings -0.04 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.620 +20.97%
on 05/16/22
1.030 -27.18%
on 04/29/22
-0.280 (-27.18%)
since 04/20/22
3-Month
0.620 +20.97%
on 05/16/22
1.190 -36.97%
on 03/14/22
-0.290 (-27.88%)
since 02/18/22
52-Week
0.620 +20.97%
on 05/16/22
2.490 -69.88%
on 09/14/21
-0.070 (-8.54%)
since 05/20/21

Most Recent Stories

More News
Alpha Cognition Announces Fourth Quarter and Full Year 2021 Results and Company Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.750 (unch)
ACOGF : 0.5880 (-0.51%)
Alpha Cognition Announces Change of CFO, Grant of Stock Options and Addition to the Board of Directors

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.750 (unch)
ACOGF : 0.5880 (-0.51%)
PTGX : 7.83 (-1.14%)
Alpha Cognition Announces Positive Data from Pre-Clinical Studies of ALPHA-0602 (Progranulin) for Amyotrophic Lateral Sclerosis (ALS)

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition” (ACI), or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform...

ACOG.VN : 0.750 (unch)
ACOGF : 0.5880 (-0.51%)
Alpha Cognition Announces Positive Neuroprotection Data from Pre-Clinical Study of ALPHA-1062 for Traumatic Brain Injury

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.750 (unch)
ACOGF : 0.5880 (-0.51%)
Alpha Cognition Announces Participation in January Investor Conferences

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.750 (unch)
ACOGF : 0.5880 (-0.51%)
Alpha Cognition Announces Director Change and Stock Option Grant

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.750 (unch)
ACOGF : 0.5880 (-0.51%)
The Power Play by The Market Herald Releases New Interviews with Rover Metals, Swarmio Media, Nextech AR and Alpha Cognition

VANCOUVER, BC / ACCESSWIRE / December 7, 2021 / The Power Play by The Market Herald has announced the release of a new interview with Rover Metals, Swarmio Media, Nextech AR and Alpha Cognition discussing...

ROVR.VN : 0.040 (+14.29%)
SWRM.CN : 0.120 (unch)
NTAR.CN : 0.445 (-10.10%)
ACOG.VN : 0.750 (unch)
Alpha Cognition Announce Data from Pre-Clinical Study of ALPHA-1062 for Traumatic Brain Injury

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

ACOG.VN : 0.750 (unch)
ACOGF : 0.5880 (-0.51%)
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021

LOS ANGELES, CA / ACCESSWIRE / December 6, 2021 / The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will be...

AKR.VN : 0.070 (+7.69%)
AKRFF : 0.0643 (-14.83%)
ADCO.TO : 0.2750 (-3.51%)
ADCOF : 0.2137 (-7.09%)
ACT.CN : 0.560 (+1.82%)
ACTHF : 0.2709 (-32.29%)
ACOG.VN : 0.750 (unch)
ACOGF : 0.5880 (-0.51%)
ALY.VN : 0.330 (+10.00%)
ATIXF : 0.2464 (+3.23%)
AQS.VN : 0.070 (+7.69%)
AQSZF : 0.0547 (+81.13%)
Alpha Cognition Appoints Cedric O’Gorman, M.D., MBA as Chief Medical Officer

Alpha Cognition Inc. (TSX-V: ACOG)(OTCQB: ACOGF)(“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives...

ACOG.VN : 0.750 (unch)
ACOGF : 0.5880 (-0.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.750
2nd Resistance Point 0.750
1st Resistance Point 0.750
Last Price 0.750
1st Support Level 0.750
2nd Support Level 0.750
3rd Support Level 0.750

See More

52-Week High 2.490
Fibonacci 61.8% 1.776
Fibonacci 50% 1.555
Fibonacci 38.2% 1.334
Last Price 0.750
52-Week Low 0.620

See More

Business Summary

Alpha Cognition Inc is a clinical-stage biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases such as Alzheimer's Disease and Amyotrophic Lateral Sclerosis. ALPHA-1062 is a patented new chemical entity that has demonstrated safety and improved tolerability...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar